Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07252947Recruiting
Stress and anxiety effects on decision-making
This study looks at how stress and anxiety affect the way people make decisions. It may help researchers understand these processes better.
New York, New YorkAges 18–65 - NCT07252726RecruitingPhase 4
Morning vs. evening dosing for metastatic breast or prostate cancer
This trial tests whether taking your hormone therapy and targeted pills in the morning or evening affects how well they work and how you feel. It is for people with metastatic breast or prostate cancer starting a specific hormone-based treatment combination.
Kitchener, OntarioAges 18 years+ - NCT07254104Enrolling by invitationEarly Phase 1
PET imaging for hard-to-treat pituitary tumors
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
BeijingAges 18–80 - NCT07253311Recruiting
Testing a rapid test for Candida auris
This trial is testing a rapid test to detect Candida auris, a hard-to-treat fungus. You can join if your doctor suspects you have this infection or you're being checked for it on your skin, and your lab sample is grown on specific plates or broths.
AthensAges 18 years+ - NCT07249879RecruitingPhase 1
CAR-T cell therapy for DLL3-positive small cell lung cancer
This trial tests a new CAR-T cell therapy (GC511B) for people with a specific type of small cell lung cancer that has DLL3 protein. The treatment uses your own immune cells to target and attack the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT07254754RecruitingPhase 2
CAR-T cell therapy for late-relapse aggressive lymphoma
This trial tests a special immune cell therapy (CAR-T cells) for people with a type of aggressive lymphoma that returned more than a year after first treatment. It aims to see if this therapy can help control the cancer again.
A Coruña, A CoruñaAges 18 years+ - NCT07254091RecruitingEarly Phase 1
Implantable chip to test chemo in pancreatic cancer surgery
This trial tests a tiny implantable device that measures how different chemotherapy drugs work on your tumor during surgery. The goal is to find the most effective treatment for your specific cancer.
New Hyde Park, New YorkAges 18 years+ - NCT07253974Recruiting
Atrial Fibrillation Stroke Recovery Study
This study follows people who had a stroke linked to atrial fibrillation (an irregular heartbeat) and are in a rehabilitation program. Researchers want to see how recovery goes and what helps patients improve.
BarcelonaAges 18–99 - NCT07251205Recruiting
Cooking program for people in recovery from substance use
This study tests a cooking and nutrition program for people living in recovery houses after treatment for substance use. It aims to help build healthier habits and support long-term recovery.
Houston, TexasAges 18 years+ - NCT07258160RecruitingPhase 2
Cordycepin for low CD8+ cells in solid tumor patients
This trial tests a supplement derived from cordyceps mushrooms to see if it can raise low CD8+ immune cell levels in people who have had solid tumors. It may help strengthen your immune system after previous cancer treatments.
Suzhou, JiangsuAges 18 years+ - NCT07253038Recruiting
Testing social skills in Huntington's disease
This study tests three different ways to measure social skills (like understanding emotions or reading social cues) in people with Huntington's disease. The goal is to find which test works best for future research and care.
LundAges 18–75 - NCT07251868Recruiting
Study of SG in breast cancer with brain metastases
This study follows patients with breast cancer that has spread to the brain and who have already received the drug Sacituzumab Govitecan (SG). The goal is to learn how well SG works in real-world settings and to see how patients are doing over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07258706Enrolling by invitation
Study on TAVI results based on patient differences
This trial is for people with severe aortic stenosis who are already scheduled for TAVI (a procedure to replace a narrowed heart valve). It looks at how individual differences affect the procedure's outcomes.
VicenzaAges 18 years+ - NCT07249983Recruiting
Video laryngeal mask study for military medics
This trial tests a video laryngeal mask (a breathing tube with a camera) used by military medics for airway management during planned surgeries. It aims to see if it works well for patients needing help breathing during anesthesia.
Prague, PragueAges 18–65 - NCT06902194Recruiting
Kids' immune response to respiratory infections study
This study looks at how South African children's immune systems respond to acute respiratory infections. It may help find better ways to treat or prevent these infections.
Cape Town, Western CapeAges Up to 13 years - NCT05269316RecruitingPhase 1/Phase 2
Early-phase study of IMP9064 for advanced solid tumors
This Phase 1/2 trial tests IMP9064, either alone or with another treatment, in people with advanced solid cancers that have stopped responding to standard care. It aims to see how well it works and how safe it is, including whether it can be used when treatment options are limited.
Hackensack, New JerseyAges 18 years+ - NCT05477849RecruitingPhase 1
Study drug for people with advanced solid tumors
This Phase 1 trial tests the safety and early effects of VG2025 in people with advanced solid cancers that have stopped responding to standard treatments. It’s mainly looking for side effects and how the body processes the drug, and it may offer a new option when other treatments haven’t worked.
Hangzhou, ZhejiangAges 18–75 - NCT05870163Recruiting
Registry study of RefluxStop for GERD patients
This registry study follows people with long-term acid reflux (GERD) who get the RefluxStop treatment. It mainly collects real-world safety and performance information to see how well the device helps over time.
FriedrichshafenAges 18 years+ - NCT06065124Recruiting
Study on weight loss surgery for heart failure with irregular heartbeat
This trial tests if weight loss surgery can help people with heart failure and atrial fibrillation (an irregular heartbeat) improve their heart condition. You may join if you are between 45 and 70, have a BMI of 32 to 40, and have mild to moderate heart failure with preserved pumping function.
Arnhem, GelderlandAges 45–70 - NCT06493890Recruiting
Validating a Dutch questionnaire for prosthesis users
This study aims to validate a Dutch version of a questionnaire that measures how well people feel their prosthetic leg works for them. The goal is to make sure the Dutch version is accurate and helpful for people with one leg amputation.
Groningen, Provincie GroningenAges 18 years+ - NCT06876272Recruiting
Testing nutrition programs for college students
This trial tests whether certain nutrition programs help college students eat better. It looks at how well these programs work and how easy they are to put in place.
Antwerp, AntwerpenAges 18–24 - NCT07243002Recruiting
Patient outcomes with ribociclib or abemaciclib for early breast cancer
This study looks at how women and men with stage II or III HR+ HER2- breast cancer do when they start treatment with ribociclib or abemaciclib (combined with hormone therapy) after surgery. Researchers want to understand real-world experiences and results.
LondonAges 18 years+ - NCT07241910RecruitingPhase 1
Testing the safety of SYH2061 in healthy volunteers
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hefei, AnhuiAges 18–55 - NCT07246564RecruitingPhase 4
Rozanolixizumab for Generalized Myasthenia Gravis in Chinese Adults
This study tests an investigational drug called rozanolixizumab for Chinese adults with generalized myasthenia gravis who have a specific antibody (AChR or MuSK) and symptoms that still affect daily activities. It aims to see if the drug helps improve muscle strength and quality of life.
BeijingAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.